Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending

IMPORTANCE: Delivering low-value care can lead to unnecessary follow-up services and associated costs, and such care cascades have not been well examined in common clinical scenarios. OBJECTIVE: To evaluate the utilization and costs of care cascades of prostate-specific antigen (PSA) tests for prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, David D., Daly, Allan T., Koethe, Benjamin C., Fendrick, A. Mark, Ollendorf, Daniel A., Wong, John B., Neumann, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682424/
https://www.ncbi.nlm.nih.gov/pubmed/36413364
http://dx.doi.org/10.1001/jamanetworkopen.2022.43449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682424/
https://www.ncbi.nlm.nih.gov/pubmed/36413364
http://dx.doi.org/10.1001/jamanetworkopen.2022.43449

Ejemplares similares